1. Home
  2. RELI vs ADIL Comparison

RELI vs ADIL Comparison

Compare RELI & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reliance Global Group Inc.

RELI

Reliance Global Group Inc.

HOLD

Current Price

$0.56

Market Cap

5.5M

Sector

Finance

ML Signal

HOLD

Logo Adial Pharmaceuticals Inc

ADIL

Adial Pharmaceuticals Inc

HOLD

Current Price

$0.24

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELI
ADIL
Founded
2013
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
6.4M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
RELI
ADIL
Price
$0.56
$0.24
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
700.3K
362.7K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
5.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,115,995.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.22
52 Week High
$3.55
$1.30

Technical Indicators

Market Signals
Indicator
RELI
ADIL
Relative Strength Index (RSI) 41.00 37.50
Support Level $0.54 $0.22
Resistance Level $0.65 $0.27
Average True Range (ATR) 0.05 0.02
MACD 0.01 0.00
Stochastic Oscillator 36.72 34.28

Price Performance

Historical Comparison
RELI
ADIL

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Share on Social Networks: